The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
Open accessAbstract
THBS2 and CA19-9 markers in human blood improve detection of pancreatic ductal adenocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Such biomarker “panels” often build upon CA 19-9 and demonstrate improved performance in early-stage disease compared with CA 19-9 alone.40–43”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S. R., Harris, J. E., Jessup, J. M., Kemeny, N. E., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,614
BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources
Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C. L., Haase, J., Janes, J. O., Huss, J. W., et al. (2009) · Genome biology · doi:10.1186/gb-2009-10-11-r130 · Cited by 1,392
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124
Good, D. J., Polverini, P. J., Rastinejad, F., Beau, M. M. L., Lemons, R. S., Frazier, W. A., & Bouck, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,051
Goonetilleke, K. S., & Siriwardena, A. K. (2006) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2006.10.004 · Cited by 880
Wagner, M., Redaelli, C., Lietz, M., Seiler, C., Friess, H., & Büchler, M. W. (2004) · British journal of surgery · doi:10.1002/bjs.4484 · Cited by 844
PEPE, M. S., Feng, Z., Janes, H., Bossuyt, P. M., & Potter, J. D. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn326 · Cited by 723
Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Bardeesy, N., Cheng, K.-H., Berger, J. H., Chu, G. C., Pahler, J., Olson, P., Hezel, A. F., Horner, J., Lauwers, G. Y., Hanahan, D., et al. (2006) · Genes & Development · doi:10.1101/gad.1478706 · Cited by 674
Mayers, J. R., Wu, C. H., Clish, C. B., Kraft, P. L., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 672
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Self-citationMicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Schultz, N. A., Dehlendorff, C., Jensen, B. V., Bjerregaard, J. K., Nielsen, K. R., Bojesen, S. E., Calatayud, D., Nielsen, S. E., Yilmaz, M., Holländer, N. H., et al. (2014) · JAMA · doi:10.1001/jama.2013.284664 · Cited by 455
Validation of the 6 th edition AJCC pancreatic cancer staging system
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Ritchey, J. D., Stewart, A. K., Winchester, D. P., & Talamonti, M. S. (2007) · Cancer · doi:10.1002/cncr.22852 · Cited by 422
Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.
Tempero, M. A., Uchida, E., Takasaki, H., Burnett, D. A., Steplewski, Z., & Pour, P. M. (1987) · PubMed · Cited by 400
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
Duffy, M. J., Sturgeon, C. M., Lamerz, R., Haglund, C. H., Holubec, V. L., Klapdor, R., Nicolini, A., Topolčan, O., & Heinemann, V. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp332 · Cited by 382
Validation techniques for logistic regression models
Miller, M. E., Hui, S. L., & Tierney, W. M. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100805 · Cited by 322
Plasma Proteome Database as a resource for proteomics research: 2014 update
Nanjappa, V., Thomas, J. K., Marimuthu, A., Muthusamy, B., Radhakrishnan, A., Sharma, R., Khan, A. A., Balakrishnan, L., Sahasrabuddhe, N. A., Kumar, S., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1251 · Cited by 315
Progression of Pancreatic Intraductal Neoplasias to Infiltrating Adenocarcinoma of the Pancreas
Brat, D. J., Lillemoe, K. D., Yeo, C. J., Warfield, P. B., & Hruban, R. H. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199802000-00003 · Cited by 309
Early Detection of Sporadic Pancreatic Cancer: Summative Review
Chari, S. T., Kelly, K., Hollingsworth, M. A., Thayer, S. P., Ahlquist, D. A., Andersen, D. K., Batra, S. K., Brentnall, T. A., Canto, M., Cleeter, D. F., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000368 · Cited by 295
Self-citationA Compendium of Potential Biomarkers of Pancreatic Cancer
Gowda, H., Kandasamy, K., Ranganathan, P., Rani, S., Ramabadran, S., Gollapudi, S., Balakrishnan, L., Dwivedi, S. B., Telikicherla, D., Selvan, L. D. N., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000046 · Cited by 285
On the Dangers of Cross-Validation. An Experimental Evaluation
Rao, R. B., Fung, G., & Rosales, R. (2008) · SIAM International Conference on Data Mining · doi:10.1137/1.9781611972788.54 · Cited by 213
Qian, W.-J., Kaleta, D. T., Petritis, B. O., Jiang, H., Liu, T., Zhang, X., Mottaz, H. M., Varnum, S. M., Camp, D. G., Huang, L., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800008-mcp200 · Cited by 208
Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma
Radon, T. P., Massat, N. J., Jones, R., Alrawashdeh, W., Dumartin, L., Ennis, D., Duffy, S. W., Kocher, H. M., Pereira, S. P., Guarner (posthumous), L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2467 · Cited by 203
Kim, J., Hoffman, J. P., Alpaugh, R. K., Rhim, A. D., Reichert, M., Stanger, B. Z., Furth, E. E., Sepulveda, A. R., Yuan, C., Won, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.036 · Cited by 198
Self-citationHawighorst, T., Velasco, P., Streit, M., Hong, Y., Kyriakides, T. R., Brown, L. F., Bornstein, P., & Detmar, M. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2631 · Cited by 149
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
Capello, M., Bantis, L. E., Scélo, G., Zhao, Y., Peng, L., Dhillon, D. S., Patel, N. J., Kundnani, D. L., Wang, H., Abbruzzese, J. L., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw266 · Cited by 148
Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer
Chan, A., Prassas, I., Dimitromanolakis, A., Brand, R. E., Serra, S., Diamandis, E. P., & Blasutig, I. M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0289 · Cited by 147
Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis
Nie, S., Lo, A., Wu, J., Zhu, J., Tan, Z., Simeone, D. M., Anderson, M. A., Shedden, K. A., Ruffin, M. T., & Lubman, D. M. (2014) · Journal of Proteome Research · doi:10.1021/pr400967x · Cited by 128
MOPED: Model Organism Protein Expression Database
Kolker, E., Higdon, R., Haynes, W. A., Welch, D., Broomall, W., Lancet, D., Stanberry, L. I., & Kolker, N. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1177 · Cited by 112
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
Bauden, M. P., Pamart, D., Ansari, D., Herzog, M., Eccleston, M., Micallef, J., Andersson, B., & Andersson, R. E. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0139-4 · Cited by 110
Familial pancreatic cancer: genetic advancesPreprint
Rustgi, A. K. (2014) · Genes & Development · doi:10.1101/gad.228452.113 · Cited by 101
Nolen, B. M., Brand, R. E., Prosser, D., Velikokhatnaya, L., Allen, P. J., Zeh, H. J., Grizzle, W. E., Lomakin, A., & Lokshin, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094928 · Cited by 94
Yu, K. H., Barry, C. G., Austin, D., Busch, C. M., Sangar, V., Rustgi, A. K., & Blair, I. A. (2009) · Journal of Proteome Research · doi:10.1021/pr800904z · Cited by 92
Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer
Sun, R., Wu, J., Chen, Y., Lu, M., Zhang, S., Lu, D., & Li, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-225 · Cited by 91
New-onset diabetes in pancreatic cancer: A study in the primary care setting
Aggarwal, G., Rabe, K. G., Petersen, G. M., & Chari, S. T. (2012) · Pancreatology · doi:10.1016/j.pan.2012.02.003 · Cited by 90
Self-citationJenkinson, C., Elliott, V. L., Evans, A., Oldfield, L., Jenkins, R. E., O'Brien, D. P., Apostolidou, S., Gentry-Maharaj, A., Fourkala, E.-O., Jacobs, I. J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0879 · Cited by 87
Chi, H., He, K., Yang, B., Chen, Z., Sun, R.-X., Fan, S., Zhang, K., Liu, C., Yuan, Z., Wang, Q.-H., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.05.009 · Cited by 71
BORNSTEIN, P. K., Devarayalu, S., Li, P., Distèche, C. M., & Framson, P. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8636 · Cited by 67
Makawita, S., Dimitromanolakis, A., Soosaipillai, A. R., Soleas, I. M., Chan, A., Gallinger, S., Haun, R. S., Blasutig, I. M., & Diamandis, E. P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-404 · Cited by 58
Satake, K., Kanazawa, G., Kho, I., Chung, Y. S., & Umeyama, K. (1985) · Journal of Surgical Oncology · doi:10.1002/jso.2930290106 · Cited by 55
Familial pancreatic adenocarcinoma
Petersen, G. M. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.04.007 · Cited by 53
Self-citationMolina, V., Visa, L., Conill, C., Navarro, S., Fernández, J. M. E., Auge, J. M., Filella, X., López-Boado, M. Á., Ferrer, J., Fernández‐Cruz, L., et al. (2011) · Tumor Biology · doi:10.1007/s13277-011-0297-8 · Cited by 53
Prassas, I., Brinc, D., Farkona, S., Leung, F., Dimitromanolakis, A., Chrystoja, C. C., Brand, R., Kulasingam, V., Blasutig, I. M., & Diamandis, E. P. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.215236 · Cited by 52
McWilliams, R. R., Bamlet, W. R., de Andrade, M., Rider, D. N., Cunningham, J. M., & Petersen, G. M. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1109 · Cited by 48
Self-citationMirus, J. E., Zhang, Y., Li, C. I., Lokshin, A. E., Prentice, R. L., Hingorani, S. R., & Lampe, P. D. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3474 · Cited by 47
Yan, L., Tonack, S., Smith, R., Dodd, S., Jenkins, R. E., Kitteringham, N., Greenhalf, W., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2009) · Journal of Proteome Research · doi:10.1021/pr800451h · Cited by 44
Research works printed but not linked: 2
- 10.1373/49.1.7 · DOI · Paper page
- 10.1016/j.gastro.2005.05.007 · DOI · Paper page
Cited by
Sorted by citations
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.056 · Cited by 918
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.023 · Cited by 578
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
The tumour glyco-code as a novel immune checkpoint for immunotherapy
RodrÍguez, E., Schetters, S. T. T., & van Kooyk, Y. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2018.3 · Cited by 473
Metadata
- Authors
- Kim, J., Bamlet, W. R., Oberg, A. L., Chaffee, K. G., Donahue, G., Cao, X.-J., Chari, S., Garcia, B. A., Petersen, G. M., & Zaret, K. S.
- Affiliations
- Abramson Cancer Center (US)
- Mayo Clinic (US)
- Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
- University of Pennsylvania (US)
- Corresponding author
- Zaret, Kenneth S.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-07-12
- Volume
- 9
- Issue
- 398
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC5727893
- OpenAlex
- W2734646423
- Cited by
- 269
- References
- 57
- Citations by year
- 2026: 18 · 2025: 17 · 2024: 24 · 2023: 22 · 2022: 39 · 2021: 52 · 2020: 39 · 2019: 23 · 2018: 29 · 2017: 6
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense (award308650, BC123187P1)
- NIH Office of the Director (award307521, DK108288-02, award308646, R01GM36477, award308647, P30DK050306, award308649, P50CA102701, award308648, R01CA208517, award308651, P30DK19525)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Keywords
- pancreatic ductal adenocarcinoma, thrombospondin-2, CA19-9, early cancer detection, plasma biomarkers, tumor staging
- MeSH terms
- Thrombospondin 2, Adenocarcinoma, Aged, Demography, Female, Humans, Male, Middle Aged, Biomarkers, Tumor, Reproducibility of Results, Case-Control Studies, CA-19-9 Antigen, Thrombospondins, Carcinoma, Pancreatic Ductal, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
